2015

1. Development of surface modified biodegradable polymeric nanoparticles to deliver GSE24.2 peptide to cells: A promising approach for the treatment of defective telomerase disorders

   European Journal of Pharmaceutics and Biopharmaceutics, Vol. 91, pp. 91-102